www.fdanews.com/articles/148202-bg-medicine-seeks-fda-clearance-for-architect-galectin-3-assay

BG Medicine Seeks FDA Clearance for ARCHITECT Galectin-3 Assay

July 26, 2012

Cardiovascular diagnostics developer BG Medicine has filed a 510(k) premarket notification with the FDA for regulatory clearance for the ARCHITECT Galectin-3 assay.
Pharmaceutical Business Review